House Publications

The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Bilingual view PDF

44th PARLIAMENT, 1st SESSION

Journals No. 251 Monday, November 20, 2023 11:00 a.m.

Prayer

Private Members' Business

At 11:00 a.m., pursuant to Standing Order 30(6), the House proceeded to the consideration of Private Members' Business.

The order was read for the second reading and reference to the Standing Committee on Agriculture and Agri-Food of Bill C-355, An Act to prohibit the export by air of horses for slaughter and to make related amendments to certain Acts.

Mr. Louis (Kitchener—Conestoga), seconded by Mr. Carr (Winnipeg South Centre), moved, — That the bill be now read a second time and referred to the Standing Committee on Agriculture and Agri-Food.

Debate arose thereon.

Pursuant to Standing Order 93(1), the order was dropped to the bottom of the order of precedence on the Order Paper.

Government Orders

Ms. Ien (Minister for Women and Gender Equality and Youth) for Ms. Gould (Leader of the Government in the House of Commons), seconded by Mr. Duclos (Minister of Public Services and Procurement), moved, — That, notwithstanding any standing order or usual practice of the House, Bill C-56, An Act to amend the Excise Tax Act and the Competition Act, shall be disposed of as follows:

(a) the bill be ordered for consideration at the second reading stage immediately after the adoption of this order;

(b) when the House resumes debate at the second reading stage of the bill,

(i) not more than one additional member of each recognized party and a member of the Green Party may each speak at the said stage for not more than 20 minutes, followed by 10 minutes for questions and comments, provided that members may be permitted to split their time with another member,

(ii) at the conclusion of the time provided for the debate at the second reading stage or when no member rises to speak, whichever is earlier, all questions necessary to dispose of the said stage of the bill shall be put forthwith and successively, without further debate or amendment, provided that, if a recorded division is requested, the vote shall not be deferred, and once proceedings at the said stage have concluded the House shall thereafter adjourn to the next sitting day;

(i) it be an instruction to the committee, that during its consideration of the bill, it be granted the power to expand its scope to,

(A) increase the maximum fixed penalty amounts for abuse of dominance to $25 million in the first instance, and $35 million for subsequent orders, for situations where this amount is higher than three times the value of the benefit derived (or the alternative variable maximum),

(B) allow the Competition Bureau to conduct market study inquiries if it is either directed by the Minister responsible for the Act or recommended by the Commissioner of Competition, and require consultation between the two officials prior to the study being commenced,

(C) revise the legal test for abuse of a dominant position prohibition order to be sufficiently met if the Tribunal finds that a dominant player has engaged in either a practice of anti-competitive acts or conduct other than superior competitive performance that had, is having or is likely to have the effect of preventing or lessening competition substantially in a relevant market,

(ii) during consideration of the bill by the committee,

(A) the committee shall have the first priority for the use of House resources for committee meetings,

(B) the committee shall meet between 3:30 p.m. up until 11:59 p.m. on the second sitting day following the adoption of the bill at second reading to gather evidence from witnesses,

(C) all amendments be submitted to the clerk of the committee by noon on the sitting day following the first meeting of the committee,

(D) amendments filed by independent members shall be deemed to have been proposed during the clause-by-clause consideration of the bill,

(E) the committee shall meet at 3:30 p.m., on the second sitting day following the first meeting to consider the bill at clause-by-clause, and if the committee has not completed the clause-by-clause consideration of the bill by 11:59 p.m., all remaining amendments submitted to the committee shall be deemed moved, the Chair shall put the question, forthwith and successively without further debate on all remaining clauses and amendments submitted to the committee as well as each and every question necessary to dispose of the clause-by-clause consideration of the bill, and the committee shall not adjourn the meeting until it has disposed of the bill,

(F) a member of the committee may report the bill to the House by depositing it with the Clerk of the House, who shall notify the House leaders of the recognized parties and independent members, and if the House stands adjourned, the report shall be deemed to have been duly presented to the House during the previous sitting for the purpose of Standing Order 76.1(1);

(d) not more than one sitting day shall be allotted to the consideration of the bill at report stage, and 15 minutes before the expiry of the time provided for Government Orders that day, or when no member rises to speak, whichever is earlier, any proceedings before the House shall be interrupted, and in turn every question necessary for the disposal of the said stage of the bill shall be put forthwith and successively, without further debate or amendment, and, if a recorded division is requested, the vote shall not be deferred; and

(e) not more than one sitting day shall be allotted to the consideration of the bill at the third reading stage and 15 minutes before the expiry of the time provided for Government Orders that day, or when no member rises to speak, whichever is earlier, any proceedings before the House shall be interrupted, and in turn every question necessary for the disposal of the said stage of the bill shall be put forthwith and successively, without further debate or amendment, and, if a recorded division is requested, the vote shall not be deferred. (Government Business No. 30)

Debate arose thereon.

Mr. Williams (Bay of Quinte), seconded by Mr. Melillo (Kenora), moved the following amendment, — That the motion be amended by adding after subparagraph (c)(ii)(B) the following:

“and the Deputy Prime Minister and Minister of Finance, the Minister of Innovation, Science and Industry, and the Minister of Housing, Infrastructure and Communities be ordered to appear as witnesses for no less than two hours each,”.

Debate arose thereon.

Statements By Members

Pursuant to Standing Order 31, members made statements.

Oral Questions

Pursuant to Standing Order 30(5), the House proceeded to Oral Questions.

Deferred Recorded Divisions

Government Orders

Pursuant to Standing Order 45, the House proceeded to the taking of the deferred recorded division on the motion of Mr. Champagne (Minister of Innovation, Science and Industry), seconded by Ms. Martinez Ferrada (Minister of Tourism and Minister responsible for the Economic Development Agency of Canada for the Regions of Quebec), — That Bill C-34, An Act to amend the Investment Canada Act, be now read a third time and do pass.
The question was put on the motion and it was agreed to on the following division:
(Division No. 449 -- Vote n^o 449)
YEAS: 309, NAYS: 0
YEAS -- POUR Aboultaif Aitchison Albas Aldag Alghabra Ali Allison Anand Anandasangaree Angus Arnold Arseneault Arya Ashton Atwin Bachrach Badawey Bains Baker Baldinelli Barlow Barrett Barron Barsalou-Duval Battiste Beaulieu Beech Bendayan Bennett Bergeron Berthold Bérubé Bezan Bibeau Bittle Blaikie Blair Blanchette-Joncas Blaney Block Blois Boissonnault Boulerice Bradford Bragdon Brassard Brière Brock Brunelle-Duceppe Calkins Cannings Caputo Carr Carrie Casey Chabot Chagger Chahal Chambers Champagne Champoux Chatel Chen Chiang Chong Collins (Hamilton East—Stoney Creek) Cooper Cormier Coteau Dabrusin Dalton Damoff Davidson DeBellefeuille Deltell d'Entremont Desbiens Desilets Desjarlais Dhaliwal Dhillon Diab Doherty Dowdall Dreeshen Drouin Dubourg Duclos Duguid Duncan (Stormont—Dundas—South Glengarry) Dzerowicz Ehsassi El-Khoury Ellis Epp Erskine-Smith Falk (Battlefords—Lloydminster) Falk (Provencher) Fast Ferreri Fillmore Findlay Fisher Fonseca Fortier Fortin Fragiskatos Fraser Freeland Gaheer Gainey Gallant Garon Garrison Gaudreau Gazan Généreux Genuis Gerretsen Gill Gladu Godin Goodridge Gould Gourde Gray Green Guilbeault Hajdu Hallan Hanley Hardie Hepfner Hoback Holland Hughes Hussen Hutchings Iacono Idlout Ien Jaczek Johns Jowhari Julian Kayabaga Kelloway Kelly Khanna Khera Kitchen Kmiec Koutrakis Kramp-Neuman Kurek Kusie Kusmierczyk Kwan Lake Lalonde Lambropoulos Lametti Lamoureux Lapointe Larouche Lattanzio Lauzon Lawrence LeBlanc Lebouthillier Lehoux Lemire Leslie Lewis (Essex) Lewis (Haldimand—Norfolk) Liepert Lightbound Lloyd Lobb Long Longfield Louis (Kitchener—Conestoga) MacAulay (Cardigan) MacDonald (Malpeque) MacGregor MacKinnon (Gatineau) Maguire Majumdar Maloney Martel Martinez Ferrada Masse Mathyssen May (Cambridge) May (Saanich—Gulf Islands) Mazier McCauley (Edmonton West) McDonald (Avalon) McGuinty McKay McLean McLeod McPherson Melillo Mendès Miao Miller Moore Morrice Morrissey Motz Murray Muys Naqvi Nater Ng Noormohamed Normandin O'Connell Oliphant O'Regan Patzer Paul-Hus Pauzé Perkins Petitpas Taylor Plamondon Poilievre Powlowski Qualtrough Redekopp Reid Richards Roberts Robillard Rodriguez Rogers Romanado Rood Rota Ruff Sahota Sajjan Samson Savard-Tremblay Scarpaleggia Scheer Schiefke Schmale Seeback Serré Sgro Shanahan Shields Shipley Sidhu (Brampton East) Sidhu (Brampton South) Simard Sinclair-Desgagné Small Sorbara Soroka Sousa Steinley Ste-Marie St-Onge Strahl Stubbs Sudds Tassi Taylor Roy Thériault Therrien Thomas Thompson Tochor Tolmie Trudeau Trudel Turnbull Uppal Valdez Van Bynen van Koeverden Van Popta Vandal Vandenbeld Vecchio Vidal Vien Viersen Vignola Villemure Virani Vis Vuong Wagantall Warkentin Waugh Webber Weiler Wilkinson Williams Williamson Yip Zahid Zarrillo Zimmer Zuberi Total: -- 309
NAYS -- CONTRE Nil--Aucun
PAIRED -- PAIRÉS Fry Housefather Khalid Lantsman Mendicino Michaud Morantz Morrison Perron Rempel Garner Sarai Sheehan Total: -- 12
Accordingly, the bill was read the third time and passed.

Daily Routine Of Business

Tabling of Documents

Pursuant to Standing Order 32(2), Mr. Lamoureux (Parliamentary Secretary to the Leader of the Government in the House of Commons) laid before the House, — Government responses, pursuant to Standing Order 36(8), to the following petitions:

— Nos. 441-01674, 441-01707, 441-01715, 441-01717 and 441-01748 concerning the environment;

— No. 441-01693 concerning awards and honours;

— No. 441-01706 concerning business and trade;

— Nos. 441-01708, 441-01709, 441-01710, 441-01711, 441-01712, 441-01713, 441-01723, 441-01724, 441-01725, 441-01728 and 441-01742 concerning justice;

— Nos. 441-01714, 441-01720, 441-01721, 441-01743, 441-01744, 441-01745, 441-01746, 441-01747 and 441-01751 concerning health;

— Nos. 441-01716, 441-01719, 441-01727, 441-01731 and 441-01740 concerning foreign affairs;

— No. 441-01718 concerning national defence and military operations;

— Nos. 441-01722 and 441-01730 concerning public safety;

— Nos. 441-01726, 441-01738 and 441-01741 concerning social affairs and equality;

— Nos. 441-01729 and 441-01735 concerning transportation;

— Nos. 441-01732, 441-01734 and 441-01739 concerning civil and human rights;

— No. 441-01733 concerning culture and heritage;

— Nos. 441-01736 and 441-01737 concerning animals;

— No. 441-01749 concerning consumer protection;

— No. 441-01750 concerning Indigenous affairs.

Presenting Reports from Committees

Ms. Sgro (Humber River—Black Creek), from the Standing Committee on International Trade, presented the 11th report of the committee, "The Underused Housing Tax: Potential impacts and proposed actions". — Sessional Paper No. 8510-441-343.

Pursuant to Standing Order 109, the committee requested that the government table a comprehensive response.

A copy of the relevant Minutes of Proceedings (Meetings Nos. 69, 70, 72, 73 and 77) was tabled.

Ms. Sgro (Humber River—Black Creek), from the Standing Committee on International Trade, presented the 12th report of the committee, "Anti-dumping and countervailing duties being applied on certain Canadian softwood lumber products". — Sessional Paper No. 8510-441-344.

Pursuant to Standing Order 109, the committee requested that the government table a comprehensive response.

A copy of the relevant Minutes of Proceedings (Meetings Nos. 64, 71, 74 and 77) was tabled.

Ms. Chagger (Waterloo), from the Standing Committee on Procedure and House Affairs, presented the 52nd report of the committee, which was as follows:

The committee recommends, pursuant to Standing Orders 104 and 114, the following changes to the lists of members of the following standing committees:

Standing Committee on Health


Jenica Atwin for Darren Fisher

Standing Committee on Public Accounts


Shaun Chen for Kody Blois

A copy of the relevant Minutes of Proceedings (Meeting No. 1) is tabled.

Motions

By unanimous consent, it was resolved, — That the 52nd report of the Standing Committee on Procedure and House Affairs, presented earlier today, be concurred in.

Presenting Petitions

Pursuant to Standing Order 36, petitions certified by the Clerk of Petitions were presented as follows:

— by Mr. Mazier (Dauphin—Swan River—Neepawa), one concerning justice (No. 441-01924);

— by Mr. Gerretsen (Kingston and the Islands), one concerning social affairs and equality (No. 441-01925);

— by Mr. Vis (Mission—Matsqui—Fraser Canyon), one concerning transportation (No. 441-01926), one concerning justice (No. 441-01927), one concerning culture and heritage (No. 441-01928) and one concerning business and trade (No. 441-01929);

— by Mr. Genuis (Sherwood Park—Fort Saskatchewan), one concerning civil and human rights (No. 441-01930) and three concerning foreign affairs (Nos. 441-01931, 441-01932 and 441-01933);

— by Mr. Arya (Nepean), one concerning civil and human rights (No. 441-01934).

Questions on the Order Paper

Mr. Lamoureux (Parliamentary Secretary to the Leader of the Government in the House of Commons) presented the answers to questions Q-1746, Q-1747, Q-1753, Q-1757, Q-1758, Q-1762, Q-1766, Q-1768 to Q-1771, Q-1777 to Q-1781, Q-1784 to Q-1786, Q-1789 to Q-1792, Q-1798 and Q-1801 on the Order Paper.

Pursuant to Standing Order 39(7), Mr. Lamoureux (Parliamentary Secretary to the Leader of the Government in the House of Commons) presented the returns to the following questions made into orders for return:

Q-1748 — — With regard to the government’s participation in negotiations for a pandemic instrument or treaty: (a) what is Canada’s current position on the pandemic treaty, specifically with regard to equitable access to medical countermeasures such as drugs and vaccines, in particular (i) why Canada has proposed that technology transfers to enable other countries to manufacture their own drugs and vaccines only occur on “voluntary and mutually agreed terms” with pharmaceutical companies, even when those drugs and vaccines were developed with public funding from the government, (ii) what Canada proposes to do in situations where pharmaceutical companies do not enter into voluntary agreements, as it frequently did not happen during the COVID-19 pandemic and previous global public health crises such as HIV, (iii) how will Canada ensure that investments of public funds, including those by Canadian taxpayers, in pharmaceutical research, development, and manufacturing, delivers affordable and globally-accessible drugs, vaccines, and other health technologies to Canadians and people worldwide; (b) how is the government implementing the recommendations from the Standing Committee on Foreign Affairs and International Development vaccine equity report entitled “Overcoming the Barriers to Global Vaccine Equity and Ending the Pandemic” during its participation in negotiations for the pandemic instrument, and will the government follow the report’s recommendation 8 that it “ensure that its agreements to provide research and development funding include clauses that allow intellectual property resulting from that funding – including vaccines, therapeutics, and diagnostics – to be easily licensed to manufacturers serving low- and middle income countries”; (c) how are the positions articulated by civil society during the Pandemic Instrument Partner and Stakeholder Engagement Forum reflected in Canada’s own positions in negotiation of the pandemic instrument; (d) which of the strategies and actions recommended by participants and contained in the government’s report on the Pandemic Instrument Partner and Stakeholder Engagement Forum does the government agree with; (e) which of the strategies and actions recommended by participants and contained in the government’s report on the Pandemic Instrument Partner and Stakeholder Engagement Forum does the government disagree with and why; and (f) how many meetings, emails and phone calls, and on what dates, have officials from (i) Global Affairs Canada, (ii) the Public Health Agency of Canada, (iii) Health Canada, (iv) the Privy Council Office, (v) Public Services and Procurement Canada, (vi) Innovation, Science and Economic Development Canada, (vii) the Office of the Prime Minister, had with (A) Innovative Medicines Canada, (B) pharmaceutical company representatives, (C) Canadian and international not-for-profit or charitable organizations, on the subject of pandemic instrument and the revision of the International Health Regulations? — Sessional Paper No. 8555-441-1748.

Q-1749 — — With regard to the government’s procurement of vaccines during the COVID-19 pandemic: (a) what price did Canada negotiate per vaccine from each manufacturer, and what was the final price paid per vaccine for each manufacturer; (b) what were the amounts, in Canadian dollars, broken down by vaccine product and company, of advance payments made by the government to pharmaceutical companies to guarantee vaccine shipments; (c) what confidentiality and indemnification clauses did Canada agree to in order to exempt companies from legal liability; (d) were pharmaceutical companies exempted from the obligation to give full refunds if deliveries were delayed or cancelled; (e) what clauses, if any, did the vaccine purchase contracts signed by Canada include relating to the ability of Canada to donate vaccine doses from those contracts to low- and middle-income countries, humanitarian organizations, Gavi, the World Health Organization, or any other organization for use outside of Canada; (f) when Canada’s Chief Public Health Officer indicated, in October 2021, that initial agreements between Canada and the manufacturers of mRNA vaccines (e.g. Moderna and Pfizer/BioNTech) did not allow for doses to be donated but that new arrangements had been made to permit donations, what were the original conditions and the subsequently agreed conditions, respectively; (g) what is the total value, in Canadian dollars, of funding provided by the government, broken down by department or agency, to support the research, development, or manufacture of vaccines, drugs, or diagnostic tests for COVID-19 between 2020 and 2023; (h) for any of the funding provided during this time to companies, universities, not-for-profits, or other research, development, or manufacturing entities, did any of the funding agreements or contracts contain clauses or stipulations that would secure a pricing structure for the final product for Canadians or for people living in low- and middle-income countries; (i) did Canada attempt to use its leverage as an investor in these technologies to secure fair or affordable pricing of the final products for Canadians or for people living in low and middle income countries; and (j) did Canada attempt to use its leverage as an investor in these technologies to ensure access to the final products for Canadians or for people living in low and middle income countries, for example by requiring the products to be registered for use in Canada or in low and middle income countries? — Sessional Paper No. 8555-441-1749.

Q-1750 — — With regard to Correctional Service Canada: what is the breakdown by security classification of the facility of how many dangerous offenders are currently in each type of facility, including those on parole or conditional release? — Sessional Paper No. 8555-441-1750.

Q-1751 — — With regard to Correctional Service Canada: what is the breakdown by security classification of the facility of how many offenders serving life sentences for multiple murders are currently in each type of facility, including those on parole or conditional release? — Sessional Paper No. 8555-441-1751.

Q-1752 — — With regard to the government’s response to drones being used in the proximity of penitentiaries or other correctional facilities, within the past five years: (a) has the government tested or used technology to jam or nullify mobile phone or drone use in relation to any penitentiary or correctional facility, and, if so, what are the details of what was done, including, for each action, the (i) date, (ii) summary of what was done; and (b) has the government consulted or sought external advice related to the drones being used to smuggle items into penitentiaries or correctional facilities, and, if so, what are the details, including the (i) name of the individual or firm, (ii) date, (iii) value of the contract, if applicable, (iv) description of the parameters for the advice or consultation sought, (v) description of the advice or information received? — Sessional Paper No. 8555-441-1752.

Q-1754 — — With regard to the upcoming tenth session of the Conference of the Parties (COP10) to the World Health Organization Framework Convention on Tobacco Control, from November 10 to 25, 2023, and the third session of the Meeting of Parties (MOP3) to the Protocol to Eliminate Illicit Trade in Tobacco Products, from November 27 to 30, 2023: (a) how many individuals will be part of the government's delegation and what are their names and titles; (b) what is the overall budget for the government's COP10 and MOP3 participation, broken down by (i) accommodations, (ii) meals or per diems, (iii) hospitality; (c) what are the government's key priorities or action items for both the COP10 and MOP3; and (d) has the government been assigned any specific agenda items or resolutions for both the COP1O and MOP3, and, if so, what are they? — Sessional Paper No. 8555-441-1754.

Q-1755 — — With regard to the Canada Child Benefit, during the most recent round of payments: (a) how many and what percentage of families who received payments got (i) the maximum payment amount for each child, (ii) a decreased payment amount due to the adjusted family net income level; and (b) of the families in (a) who received a decreased amount, what was the number and percentage of recipients that had their payments reduced by (i) less than 25 percent, (ii) 25 to 50 percent, (iii) more than 50 percent to 75 percent, (iv) more than 75 percent? — Sessional Paper No. 8555-441-1755.

Q-1756 — — With regard to workplace and work-related injuries in the public sector, broken down by department and fiscal year since 2015-16: (a) what is the total number of public sector workers who experienced (i) physical injuries in the workplace, (ii) injuries to their mental health or mental well-being in the workplace; (b) how many of the workers in (a) experienced injuries that resulted in the worker being unable to work either (i) temporarily, (ii) permanently, (iii) to the full extent of their job duties prior to their injury; (c) how many of the workers in (a) experienced injuries that resulted in a leave of work of (i) less than one month, (ii) one to three months, (iii) three to six months, (iv) six to 12 months, (v) 12 months or more; (d) of the workers who experienced injuries in (a), how many saw reduced or modified job duties for (i) less than one month, (ii) one to three months, (iii) three to six months, (iv) six to 12 months, (v) more than 12 months; and (e) how many workers in (a) were (i) permanently unable to work, (ii) unable to work in the same role, (iii) required to change work place or job title? — Sessional Paper No. 8555-441-1756.

Q-1759 — — With regard to contraband items seized in federal penitentiaries, broken down by year for each of the last five years: what is the breakdown of the items seized, including the volume of each type of item seized, in total and broken down by correctional institution? — Sessional Paper No. 8555-441-1759.

Q-1760 — — With regard to the government’s response to drug addiction: (a) what are the government’s estimates on the number of Canadians who are addicted to illicit drugs, broken down by substance; (b) for each substance in (a), what is the government’s strategy to get those addicted into treatment and recovery, or to otherwise stop the addiction; (c) how much funding is being provided for the treatment and recovery strategy, broken down by year for the next five years; and (d) what are the government’s targets on how many fewer people will be addicted to each substance in (a), broken down by substance and year for the next five years? — Sessional Paper No. 8555-441-1760.

Q-1761 — — With regard to Health Canada and the Public Health Agency of Canada: (a) was each COVID-19 vaccine approved for use in Canada tested for safety against placebo prior to licensing, and, if not, which ones were exempted from the testing and why; (b) what specific ongoing studies and clinical trials is the government monitoring to compare the COVID vaccines against placebo, and what are the citations for each clinical trial; (c) which studies is the government monitoring to determine all-cause mortality after vaccination for COVID-19 and if there are any findings of correlation or causation as it relates to the COVID-19 vaccination campaign; and (d) what are the citations for each study in (c)? — Sessional Paper No. 8555-441-1761.

Q-1763 — — With regard to the Canada Revenue Agency (CRA) and CRA call centre operations, broken down by fiscal year from 2015-16 to 2023-24: (a) what was, or is, the total budget for all CRA call centre operations; (b) what was, or is, the total employee count for all CRA call centre operations; (c) for each 1-800 number which Canadians can use to call the CRA, broken down by number, (i) how many calls were received, (ii) what was the average wait time or time on hold for callers to speak to a CRA call centre agent, (iii) what was the wait time service standard, (iv) what is the number of calls that were still being blocked or receiving busy signals in the manner noted in the 2017 Fall Reports of the Auditor General of Canada to the Parliament of Canada, entitled “Report 2—Call Centres—Canada Revenue Agency”; (d) for which 1-800 numbers is the call centre system able to record calls; (e) what studies have been conducted, using a random sample of CRA call centre agents from across the country, to effectively and independently measure the percentage of accurate responses provided by CRA call centre agents; and (f) for each study in (e), (i) who conducted the study, (ii) what questions were asked, (iii) what were the results, including the numbers and percentage of inaccurate responses by CRA call centre agents to each question and 1-800 number? — Sessional Paper No. 8555-441-1763.

Q-1764 — — With regard to expenditures related to the Cabinet retreat which took place in Charlottetown, Prince Edward Island, from August 21 to 23, 2023: (a) what are the total expenditures related to the retreat; (b) what is the breakdown of the expenditures by type of expense (accommodation, hospitality, audio-visual, etc.); and (c) what are the details of all expenditures in excess of $1,000, including, for each, the (i) amount, (ii) vendor, (iii) description of the goods or services provided? — Sessional Paper No. 8555-441-1764.

Q-1765 — — With regard to all memorandums, briefing notes, and other documents sent from or received by the Privy Council Office related to, or which mention in any way, Ukrainian President Volodymyr Zelenskyy's visit to Parliament on September 22, 2023: what are the details of each, including the (i) date, (ii) sender, (iii) recipient, (iv) type of document, (v) title, (vi) summary of the contents, (vii) file number? — Sessional Paper No. 8555-441-1765.

Q-1767 — — With regard to all memorandums, briefing notes, and other documents sent from or received by Global Affairs Canada related to, or which mention in any way, Ukrainian President Volodymyr Zelenskyy's visit to Parliament on September 22, 2023: what are the details of each, including the (i) date, (ii) sender, (iii) recipient, (iv) type of document, (v) title, (vi) summary of the contents, (vii) file number? — Sessional Paper No. 8555-441-1767.

Q-1772 — — With regard to the government’s Directive on Automated Decision-Making, since March 4, 2019, broken down by department or agency: (a) did the department conduct any algorithmic impact assessments; (b) what was the conclusion of each assessment in (a), including the (i) information technology or automated decision system assessed, (ii) date the assessment was completed, (iii) impact assessment level results; (c) does the department currently license, subscribe to, or otherwise procure services from an entity that provides artificial intelligence or automated decision-making services; (d) what are the details of all procurement contracts in (c), including the (i) name of the company contracted, (ii) name of the product provided, (iii) amount paid by the department or agency; (e) was the department or any individuals within the department found in non-compliance with the directive; and (f) what consequences were applied for each instance in (e)? — Sessional Paper No. 8555-441-1772.

Q-1773 — — With regard to the government’s consultations on a generative artificial intelligence code of conduct since August 1, 2023: (a) how many consultations has the government held on this proposal; (b) how many stakeholders has the government consulted with on this proposal; (c) what are the details of the consultations, including, for each, the (i) names of the organizations consulted, (ii) date, (iii) outcome, recommendation or feedback; (d) what is the total cost of all consultations which have occurred to date; (e) what is the breakdown of (d) by date and line item; (f) have any outside consultants or service providers been involved in the development of this policy and any related consultations, and, if so, what are the details of each consultant or service provider's involvement, including the (i) name of the individual or firm, (ii) contract value, (iii) date of the contract, (iv) description of the goods or services provided; (g) what are all specific concerns that have been raised to date in the consultations; (h) how many government employees or full-time equivalents have worked on the consultations; (i) what are the travel costs associated with the consultations incurred to date (i) in total, (ii) broken down by year and type of expense; and (j) what is the current status of this policy proposal? — Sessional Paper No. 8555-441-1773.

Q-1774 — — With regard to the use of facial recognition software by the government since November 4, 2015: (a) which departments, agencies, Crown corporations, or other government entities use facial recognition software, and, for each one that uses the software, what is the (i) stated purpose, (ii) scope of use; (b) what ethical implications and concerns has the government sought to mitigate in its use of facial recognition within any government department or agency; (c) how has the government sought to mitigate each of the implications and concerns in (b); and (d) what measures has the government put in place to address algorithmic issues and racial profiling in its use of facial recognition software? — Sessional Paper No. 8555-441-1774.

Q-1775 — — With regard to any spending by any department, agency, or other government entity for receptions, trade shows, fairs or festivals held outside of Canada since January 1, 2016, broken down by year: (a) how many receptions, trade shows, fairs or festivals held overseas has the government funded; (b) what are the names and dates of all international festivals, international fairs or trade shows held overseas that the government has spent money on; (c) what are the details of each event in (b), including, for each, the (i) total spendings by the federal government on the event, (ii) rationale for the funding, (iii) breakdown of what the funds were spent on; and (d) what was the total funding for festivals, international fairs or trade shows held overseas by the government since 2016, broken down by year? — Sessional Paper No. 8555-441-1775.

Q-1776 — — With regard to the government’s safe supply initiative: (a) how much (i) heroin, (ii) crack cocaine, (iii) cocaine, (iv) fentanyl, (v) methamphetamine or crystal methamphetamine, (vi) other substance, broken down by type, does the government estimate was distributed as part of safe supply, in total and broken down by year since 2018; and (b) what is the breakdown of (a) by province or territory? — Sessional Paper No. 8555-441-1776.

Q-1782 — — With regard to the seizure of drugs by the Canada Border Services Agency since January 1, 2022, broken down by month and by type of drug: (a) what is the quantity of drugs that was seized; (b) how many shipments were seized; and (c) what is the breakdown of (a) and (b) by country of origin, or suspected country of origin? — Sessional Paper No. 8555-441-1782.

Q-1783 — — With regard to media reports that the Minister of Environment and Climate Change and his exempt staff incurred more than $700,000 in travel expenses last year: what are the estimated carbon emissions from this travel? — Sessional Paper No. 8555-441-1783.

Q-1787 — — With regard to the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law): (a) has Health Canada published the reports of serious adverse drug reactions from each Canadian hospital, either monthly or annually, to alert doctors and patients of which hospital is in breach of the act, and, if not, why not; (b) how many meetings have Health Canada officials had with drug makers or their representatives since Vanessa’s Law received royal assent in November 2014, related to the implementation of measures in the act; (c) what are the details of each meeting in (b), including, for each, the (i) date, (ii) attendees, (iii) topics discussed, (iv) type and purpose of the meeting; (d) what is the position of Health Canada regarding hospitals which have either not been reporting or underreporting serious adverse drug reactions since the regulations were enacted in 2019; (e) what specific actions, if any, did Health Canada take or is taking to ensure that hospitals comply with Vanessa’s Law; (f) what is the date of each action in (e); (g) how did Health Canada use the information on adverse drug reactions collected from hospitals to take the regulatory actions prescribed in Vanessa’s Law, broken down by drug; and (h) what are the details of all regulatory actions taken in (g), including, for each, the (i) date, (ii) drug, (iii) summary of the actions taken? — Sessional Paper No. 8555-441-1787.

Q-1788 — — With regard to Sustainable Development Technology Canada (SDTC): (a) what are the details of all funding which SDTC provided to businesses since January 1, 2020, including, for each, the (i) recipient, (ii) date, (iii) amount, (iv) type of funding (loan, grant, etc.), (v) purpose of the funding; and (b) for each loan in (a), how much has been repaid? — Sessional Paper No. 8555-441-1788.

Q-1795 — — With regard to items and services funded by Indigenous Services Canada under Jordan’s Principle since 2016, broken down by funding stream: (a) what are the details of all funding provided, including, for each, the (i) date, (ii) amount, (iii) recipient, (iv) description of the items or services; and (b) what was the total amount spent per year under Jordan’s Principle? — Sessional Paper No. 8555-441-1795.

Q-1796 — — With regard to Employment and Social Development Canada’s Skills for Success Program and the Training and Tools Stream: (a) what is the total amount granted under this program for the year 2023, and, of this amount, how much has been granted to Quebec-based organizations; (b) of all the projects selected, how many are designed to serve a francophone population or clientele; and (c) what are all the projects selected and the amounts granted for each of them? — Sessional Paper No. 8555-441-1796.

Q-1797 — — With regard to at-risk pay and performance bonuses for those classified as executive and above at Crown-Indigenous Relations and Northern Affairs Canada, and Indigenous Services Canada, since 2018, broken down by year and by type of job: (a) what specific criteria was used to determine if executives received (i) at-risk pay, (ii) performance bonuses, (iii) neither at-risk pay nor performance bonuses; and (b) what number and percentage of executives received (i) both at-risk pay and performance bonuses, (ii) at-risk pay only, (iii) neither at-risk pay nor performance bonuses? — Sessional Paper No. 8555-441-1797.

Q-1799 — — With regard to Canada Border Services Agency (CBSA) officers serving the United States—Canada land border: (a) does the government consider the CBSA officers protecting the land border to be public safety officers; (b) what is the number of CBSA officers who have worked at CBSA for (i) under five years, (ii) five to 10 years, (iii) 10 to 15 years, (iv) 15 to 20 years, (v) 20 to 25 years, (vi) more than 25 years; and (c) how many CBSA officers are currently on (i) long-term leave, (ii) administrative leave, (iii) short-term leave, for health and safety reasons? — Sessional Paper No. 8555-441-1799.

Q-1800 — — With regard to the Canada Summer Jobs program: (a) for each of the 338 federal ridings, (i) how much money, (ii) how many positions, (iii) how many hours of work, were allocated for fiscal year 2023-24; (b) for each of the 338 federal ridings, (i) how much money, (ii) how many positions, (iii) how many hours, were requested for fiscal year 2023-24; (c) for each of the 338 federal ridings, what is the numerical difference between the amount of money requested and the amount of money received; (d) for each of the 338 federal ridings, what is the numerical difference between the number of positions requested and the number of positions granted; (e) for each of the 338 federal ridings, what is the numerical difference between the number of hours requested and the number of hours granted; (f) what is, in mathematical terms, and defining all variables, the formula that was used in fiscal year 2023-24 to determine the funding allocated to each riding; and (g) what is the share of overall funding, expressed both as a percentage and in dollars, that has been allocated to federal ridings in Quebec, broken down by fiscal year, since 2006-07? — Sessional Paper No. 8555-441-1800.

Q-1802 — — With regard to the Department of Fisheries and Oceans and snow crab fisheries in Newfoundland and Labrador, since January 1, 2023: (a) what are the details of all meetings held by the Minister of Fisheries, Oceans and the Canadian Coast Guard and departmental staff concerning emergency supports for harvesters, including the (i) date of the meeting, (ii) individuals or organizations in attendance, (iii) government officials in attendance; and (b) what investments has the government made to protect existing investments and infrastructure of the inshore, owner-operator fishery and rural communities that rely on the industry? — Sessional Paper No. 8555-441-1802.

Government Orders

The House resumed consideration of the motion of Ms. Ng (Minister of Export Promotion, International Trade and Economic Development), seconded by Ms. Ien (Minister for Women and Gender Equality and Youth), — That Bill C-57, An Act to implement the 2023 Free Trade Agreement between Canada and Ukraine, be now read a second time and referred to the Standing Committee on International Trade.

The debate continued.

The question was put on the motion and, pursuant to Standing Order 45, the recorded division was deferred until Tuesday, November 21, 2023, at the expiry of the time provided for Oral Questions.

Returns and Reports Deposited with the Acting Clerk of the House

Pursuant to Standing Order 32(1), papers deposited with the Acting Clerk of the House were laid before the House as follows:

— by the Speaker — Report of the Parliamentary Budget Officer entitled "The Canada Disability Benefit: Model and Scenarios", pursuant to the Parliament of Canada Act, R.S. 1985, c. P-1, sbs. 79.2(2). — Sessional Paper No. 8560-441-1119-93. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities)

— by the Speaker — Report of the Parliamentary Budget Officer entitled "Supplementary Estimates (B) 2023-24", pursuant to the Parliament of Canada Act, R.S. 1985, c. P-1, sbs. 79.2(2). — Sessional Paper No. 8560-441-1119-94. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Government Operations and Estimates)

— by the Speaker — Report of the Parliamentary Budget Officer entitled "Costing Support for EV Battery Manufacturing", pursuant to the Parliament of Canada Act, R.S. 1985, c. P-1, sbs. 79.2(2). — Sessional Paper No. 8560-441-1119-95. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Finance)

— by the Speaker — Costing note from the Parliamentary Budget Officer on pausing the fuel charge on heating oil and doubling the rural top-up rate for fuel charge rebates, pursuant to the Parliament of Canada Act, R.S. 1985, c. P-1, sbs. 79.2(2). — Sessional Paper No. 8560-441-1119-96. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Finance)

— by Mr. Holland (Minister of Health) — Report on the National Strategy for Alzheimer's Disease and Other Dementias for the year 2023, pursuant to the National Strategy for Alzheimer's Disease and Other Dementias Act, S.C. 2017, c. 19, s. 5. — Sessional Paper No. 8560-441-1225-03. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)

— by Ms. Joly (Minister of Foreign Affairs) — Copies of the Regulations Amending the Special Economic Measures (Russia) Regulations (P.C. 2023-1121, P.C. 1122, P.C. 1123 and P.C. 2023-1124), pursuant to the Special Economic Measures Act, S.C. 1992, c. 17, sbs. 7(1). — Sessional Paper No. 8560-441-495-57. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Foreign Affairs and International Development)

— by Mrs. Lebouthillier (Minister of Fisheries, Oceans and the Canadian Coast Guard) and Mr. Guilbeault (Minister of Environment and Climate Change) — Report on the administration and enforcement of the fisheries protection and pollution prevention provisions of the Fisheries Act for the fiscal year ended March 31, 2021, pursuant to the Fisheries Act, R.S. 1985, c. F-14, sbs. 42.1(1). — Sessional Paper No. 8560-441-325-02. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Fisheries and Oceans)

Adjournment Proceedings

At 5:19 p.m., by unanimous consent and pursuant to Standing Order 38(1), the question “That this House do now adjourn” was deemed to have been proposed.

After debate, the question was deemed to have been adopted.

Accordingly, at 5:40 p.m., the Speaker adjourned the House until tomorrow at 10:00 a.m., pursuant to Standing Order 24(1).